Presse

Nobel Biocare and Materialise Dental announced today that they have reached a settlement regarding the outstanding patent litigation between them.

Following this settlement, Nobel Biocare will take a license in several Materialise patents, including the patents at suit in Germany and the USA. Nobel Biocare will receive a non-exclusive worldwide license in the dental and cranio-maxillofacial field, according to Materialise’s patent (EP) 0 756 735 and US 5,768,134.

In return, Materialise Dental will receive payments from Nobel Biocare. The parties will not disclose the amount of payments.

Bart Swaelens, CEO of Materialise Dental, added: “We are pleased to have reached this settlement. By finally closing this chapter, we can further fully focus on the development of trend-setting products in Digital Dentistry. This settlement confirms our strong patent position which we created through years of Research and Development, and it is the best solution for all dentists and patients.”